Eagle Pharmaceuticals (EGRX)

$1.65 -0.15 (-8.33%)
Market Cap 23.38M
Revenue (ttm) 316.61M
Net Income (ttm) 35.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 11.26%
Debt to Equity Ratio 0.28
Volume 501
Avg Vol 7,928
Day's Range N/A - N/A
Shares Out 12.99M
Stochastic %K 82%
Beta 0.83
Analysts Strong Buy
Price Target $17.00

Company Profile

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on manufacturing, developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company's product portfolio offers RYANODEX for malignant hyperthermia; and BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. It also produces PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 201 326 5300
Address:
50 Tice Boulevard, Suite 315, Woodcliff Lake, United States
11thestate
11thestate Apr. 17 at 1:44 PM
$EGRX — Eagle Pharmaceuticals reached a tentative settlement Held between 8/9/2022–10/1/2024? Settlement amount still being finalized but your application will be queued. Eagle promoted its chemo drug PEMFEXY as a revenue driver while a key wholesaler was sitting on expiring inventory. When Eagle restated revenue in May 2023, the stock dropped. Investors sued. A settlement was reached. Waiting for court's final approval. ➡️ Apply here: https://11th.com/cases/eagle-investor-suit
0 · Reply
Luckyluciano
Luckyluciano Apr. 16 at 12:58 PM
$EGRX Are these class acyion lawsuits legit or are they scams?
1 · Reply
11thestate
11thestate Apr. 2 at 2:05 PM
$EGRX investors: a new settlement has been reached! Eagle Pharmaceuticals has agreed to settle claims that it misled investors about the performance of its cancer drug PEMFEXY, hiding inventory problems at a key wholesale customer while continuing to report strong demand. Now, investors who were caught holding the bag have a chance to recover. 🗓️ Class Period: August 9, 2022 – October 1, 2024 ⏳ Settlement terms are still being finalized, but you can submit your early claim now. 👉 Submit your application here: https://11th.com/cases/eagle-investor-suit
0 · Reply
Freddy7672
Freddy7672 Apr. 1 at 9:10 PM
$EGRX Nantahala and the board trying hard to show court there’s no money here strategically
0 · Reply
11thestate
11thestate Mar. 25 at 2:24 PM
A common question: what about legal fees? Here's how it works: attorney fees in $EGRX settlement are approved separately by the court — and are capped by law. They don't come out of your payout. The fund set aside for investors is exactly that — for investors. If you bought between August 9, 2022, and October 1, 2024, what's waiting for you has nothing to do with what the lawyers earn. Check your eligibility here: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Mar. 24 at 3:29 PM
This settlement has no impact on $EGRX stock price. Eagle Pharmaceuticals already reached an agreement with investors. The case is closed. The settlement fund doesn't come from current operations — it comes from a legal process that has already concluded. You can still be a shareholder and file a claim at the same time. They're not mutually exclusive. If you bought between August 9, 2022 and October 1, 2024, check if you qualify: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Mar. 20 at 3:13 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there's some good news. $EGRX investors — you might be surprised, but you actually have a chance to recover your losses. Don't miss it: https://11th.com/cases/eagle-investor-suit
0 · Reply
Freddy7672
Freddy7672 Mar. 20 at 6:54 AM
$EGRX Chris joined Eagle pharmaceutical after the company was delisted from the Nasdaq and defaulted on its debt with the goal to rebuild the financial organization, get the company current and partner with the CEO and board to drive shareholder value.
2 · Reply
Freddy7672
Freddy7672 Mar. 18 at 8:06 AM
$EGRX thanks to Tariff ea 114 is 5 yrs late.
1 · Reply
Freddy7672
Freddy7672 Mar. 18 at 6:28 AM
$EGRX it
0 · Reply
Latest News on EGRX
No data available.
11thestate
11thestate Apr. 17 at 1:44 PM
$EGRX — Eagle Pharmaceuticals reached a tentative settlement Held between 8/9/2022–10/1/2024? Settlement amount still being finalized but your application will be queued. Eagle promoted its chemo drug PEMFEXY as a revenue driver while a key wholesaler was sitting on expiring inventory. When Eagle restated revenue in May 2023, the stock dropped. Investors sued. A settlement was reached. Waiting for court's final approval. ➡️ Apply here: https://11th.com/cases/eagle-investor-suit
0 · Reply
Luckyluciano
Luckyluciano Apr. 16 at 12:58 PM
$EGRX Are these class acyion lawsuits legit or are they scams?
1 · Reply
11thestate
11thestate Apr. 2 at 2:05 PM
$EGRX investors: a new settlement has been reached! Eagle Pharmaceuticals has agreed to settle claims that it misled investors about the performance of its cancer drug PEMFEXY, hiding inventory problems at a key wholesale customer while continuing to report strong demand. Now, investors who were caught holding the bag have a chance to recover. 🗓️ Class Period: August 9, 2022 – October 1, 2024 ⏳ Settlement terms are still being finalized, but you can submit your early claim now. 👉 Submit your application here: https://11th.com/cases/eagle-investor-suit
0 · Reply
Freddy7672
Freddy7672 Apr. 1 at 9:10 PM
$EGRX Nantahala and the board trying hard to show court there’s no money here strategically
0 · Reply
11thestate
11thestate Mar. 25 at 2:24 PM
A common question: what about legal fees? Here's how it works: attorney fees in $EGRX settlement are approved separately by the court — and are capped by law. They don't come out of your payout. The fund set aside for investors is exactly that — for investors. If you bought between August 9, 2022, and October 1, 2024, what's waiting for you has nothing to do with what the lawyers earn. Check your eligibility here: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Mar. 24 at 3:29 PM
This settlement has no impact on $EGRX stock price. Eagle Pharmaceuticals already reached an agreement with investors. The case is closed. The settlement fund doesn't come from current operations — it comes from a legal process that has already concluded. You can still be a shareholder and file a claim at the same time. They're not mutually exclusive. If you bought between August 9, 2022 and October 1, 2024, check if you qualify: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Mar. 20 at 3:13 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there's some good news. $EGRX investors — you might be surprised, but you actually have a chance to recover your losses. Don't miss it: https://11th.com/cases/eagle-investor-suit
0 · Reply
Freddy7672
Freddy7672 Mar. 20 at 6:54 AM
$EGRX Chris joined Eagle pharmaceutical after the company was delisted from the Nasdaq and defaulted on its debt with the goal to rebuild the financial organization, get the company current and partner with the CEO and board to drive shareholder value.
2 · Reply
Freddy7672
Freddy7672 Mar. 18 at 8:06 AM
$EGRX thanks to Tariff ea 114 is 5 yrs late.
1 · Reply
Freddy7672
Freddy7672 Mar. 18 at 6:28 AM
$EGRX it
0 · Reply
Freddy7672
Freddy7672 Mar. 18 at 1:47 AM
$EGRX spell wonderful 800% up
0 · Reply
11thestate
11thestate Mar. 17 at 10:28 AM
Don't forget that there is also an important settlement to watch for $EGRX We have every detail, including how investors can get paid: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Mar. 10 at 1:46 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there's a way to get some money back. To all $EGRX investors out there, we've got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
Freddy7672
Freddy7672 Mar. 4 at 7:16 AM
$EGRX Nantahala let's go, Chapter 7 or 11 to take her for yourself??
3 · Reply
11thestate
11thestate Feb. 27 at 12:35 PM
$EGRX has agreed to settle with investors over claims that it misled them about product performance and financial controls related to its cancer drug PEMFEXY®. Who’s eligible? Anyone who purchased $EGRX shares between August 9, 2022 and October 1, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? No payout per share has been announced yet. Can I still file? Yes. When do payouts happen? Typically within 8–12 months after final court approval of the settlement, once the terms are finalized and approved. To file your claim: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Feb. 18 at 3:51 PM
Imagine buying $EGRX at its peak, only to watch it tumble — and then learning there may be a way to recover some of your losses. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Feb. 6 at 1:13 PM
With everything going on around $EGRX lately — this is the info you don’t want to miss: https://11th.com/cases/eagle-investor-suit
0 · Reply
Freddy7672
Freddy7672 Jan. 25 at 7:50 AM
$EGRX Time bomb!-https://academic.oup.com/ofid/article/13/Supplement_1/ofaf695.1411/8421474
3 · Reply
11thestate
11thestate Jan. 16 at 2:43 PM
$EGRX has agreed to settle with investors over claims that it misled them about product performance, revenue reporting, and internal financial controls related to its cancer drug PEMFEXY. Who’s eligible? Anyone who purchased $EGRX shares between August 9, 2022 and October 1, 2024. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share has not been determined yet. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/eagle-investor-suit
0 · Reply
Biocuda
Biocuda Jan. 8 at 10:40 PM
$EGRX coming up soon January 14, 2026 – PDUFA goal date noted for EA-114 review
2 · Reply
11thestate
11thestate Jan. 6 at 2:49 PM
$EGRX investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/eagle-investor-suit
0 · Reply
11thestate
11thestate Dec. 23 at 2:59 PM
When we see a stock like this, we know how many damaged investors are out there. Believe it or not, there’s some good news. $EGRX investors — you might be surprised, but you actually have a chance to recover your losses. Don’t miss it: https://11th.com/cases/eagle-investor-suit
0 · Reply